Corporate News 25-Mar-25
Concord Biotech commences production at Unit 4 in Valthera
Concord Biotech has successfully commissioned and commenced production of injectable at its new manufacturing facility (Unit 4) situated at Valthera.
Previous News
Concord Biotech consolidated net profit rises 18.17% in the September 2024 quarter
( Results - Announcements 11-Nov-24 15:41 )
Concord Biotech commences production at Unit 4 in Valthera
( Corporate News - 25-Mar-25 12:21 )
Concord Biotech receives GMP certificate from Brazilian Health Regulatory Agency
( Corporate News - 06-Mar-24 15:22 )
Fusion Micro Finance Ltd leads losers in 'A' group
( Hot Pursuit - 23-Sep-24 15:00 )
Board of Concord Biotech recommends final dividend
( Corporate News - 23-May-24 19:01 )
Concord Biotech consolidated net profit rises 3.86% in the March 2024 quarter
( Results - Announcements 23-May-24 17:16 )
Concord Biotech IPO subscribed 24.86 times
( IPO Centre - IPO News 08-Aug-23 17:36 )
Concord Biotech consolidated net profit rises 268.78% in the September 2023 quarter
( Results - Announcements 09-Nov-23 07:51 )
Concord Biotech IPO subscribed 58%
( IPO Centre - IPO News 04-Aug-23 17:15 )
Concord Biotech jumps on receiving EIR from USFDA for Gujarat facility
( Hot Pursuit - 18-Aug-23 15:58 )
Concord Biotech rebounds after 7-day losing streak
( Hot Pursuit - 18-Feb-25 13:54 )
Other Stories
Alan Scott Industries schedules board meeting
19-Apr-25 17:34
Hatsun Agro Product schedules board meeting
19-Apr-25 17:34
Board of ICICI Bank recommends final dividend
19-Apr-25 16:52
Kothari Products schedules board meeting
19-Apr-25 16:51
Shree Karthik Papers to table results
19-Apr-25 16:51
Board of HDFC Bank recommends final dividend
19-Apr-25 16:51
Bank of Maharashtra to conduct board meeting
19-Apr-25 16:51
Mahindra EPC Irrigation to hold AGM
19-Apr-25 16:47
Ambo Agritec to convene EGM
19-Apr-25 16:47
Vakrangee announces board meeting date
19-Apr-25 15:26
Back
Top
